A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability

Cancer Research

Volumn 64, Issue 12, 2004, Pages 4244-4250

  Vos, Michele D ^a   Martinez, Alfredo ^a   Elam, Candice ^a   Dallol, Ashraf ^b   Taylor, Barbara J ^a   Latif, Farida ^b   Clark, Geoffrey J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TUBULIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; GENE FREQUENCY; GENE INACTIVATION; HUMAN; HUMAN CELL; MICROTUBULE; MITOSIS SPINDLE; MOLECULAR STABILITY; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; GENOMIC INSTABILITY; HUMANS; MICROTUBULES; MUTATION; RAS PROTEINS; TRANSFECTION; TUBULIN; TUMOR SUPPRESSOR PROTEINS;

EID: 3042655534     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0339     Document Type: Article

References (31)

1. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000;25:315-9.
2. Pfeifer GP, Yoon JH, Liu L, Tommasi S, Wilczynski SP, Dammann R. Methylation of the RASSF1A gene in human cancers. Biol Chem 2002;383:907-14.
3. Vos MD, Clark GJ. The pro-apoptotic Ras effector Norel serves as a Ras-regulated tumor suppressor in the lung. J Biol Chem 2003;278:28045-51.
4. Vos MD, Ellis CA, Elam C, Ulku AS, Taylor BJ, Clark GJ. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J Biol Chem 2003;278: 28045-51.
5. Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 2000;275:35669-72.
6. Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, Zhang XF, Seed B, Avruch J. Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 2002;12:253-65.
7. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002;22:4309-18.
8. Kuzmin I, Gillespie JW, Protopopov A, et al. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res 2002;62:3498-502.
9. Williams JG, Drugan JK, Yi GS, Clark GJ, Der CJ, Campbell SL. Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions. J Biol Chem 2000;275:22172-9.
10. Ortiz-Vega S, Khokhlatchev A, Nedwidek M, et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Norel. Oncogene 2002;21:1381-90.
11. Shiloh Y, Kastan MB. ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 2001;83:209-54.
12. Liu L, Tommasi S, Lee DH, Dammann R, Pfeifer GP. Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 2003;22:8125-36.
13. Matsuyama A, Shimazu T, Sumida Y, et al. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J 2002;21:6820-31.
14. Wassmann K, Benezra R. Mitotic checkpoints: from yeast to cancer. Curr Opin Genet Dev 2001;11:83-90.
15. Denko NC, Giaccia AJ, Stringer JR, Stambrook PJ. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc Natl Acad Sci USA 1994;91:5124-8.
16. Agapova LS, Ivanov AV, Sablina AA, et al. p53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints. Oncogene 1999; 18:3135-42.
17. Saavedra HI, Knauf JA, Shirokawa JM, et al. The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway. Oncogene 2000;19:3948-54.
18. Faivre J, Frank-Vaillant M, Poulhe R, et al. Centrosome overduplication, increased ploidy and transformation in cells expressing endoplasmic reticulum-associated cyclin A2. Oncogene 2002;21:1493.
19. Dreijerink K, Braga E, Kuzmin I, et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 2001;98:7504-9.
20. Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 2002;36: 617-56.
21. Dobles M, Liberal V, Scott ML, Benezra R, Sorger PK. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 2000;101: 635-45.
22. Pietenpol JA, Stewart ZA. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 2002;181-182:475-81.
23. Gorbsky GJ. The mitotic spindle checkpoint. Curr Biol 2001;11:R1001-4.
24. Levitt NC, Hickson ID. Caretaker tumour suppressor genes that defend genome integrity. Trends Mol Med 2002;8:179-86.
25. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3:155-68.
26. Gumy-Pause F, Wacker P, Sappino AP. ATM gene and lymphoid malignancies. Leukemia 2004;18:238-42.
27. Thissen JA, Gross JM, Subramanian K, Meyer T, Casey PJ. Prenylation-dependent association of Ki-Ras with microtubules: evidence for a role in subcellular trafficking. J Biol Chem 1997;272:30362-70.
28. Hsu LC, Doan TP, White RL. Identification of a γ-tubulin-binding domain in BRCA1. Cancer Res 2001;61:7713-8.
29. Deng CX. Roles of BRCA1 in centrosome duplication. Oncogene 2002;21:6222-7.
30. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001;1:55-67.
31. Nakamura M, Zhou XZ, Lu KP. Critical role for the EB1 and APC interaction in the regulation of microtubule polymerization. Curr Biol, 2001;11:1062-7.